Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in Princeton, NJ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
BOERNER CHRISTOPHER S. | Chief Executive Officer | Nov 28 | Buy | 48.86 | 3,071 | 150,049 | 79,384 | Nov 30 06:32 PM | Samuels Theodore R. II | Director | Nov 20 | Buy | 49.81 | 8,500 | 423,385 | 35,500 | Nov 21 07:01 PM | Powell Ann | EVP, Chief Human Resources | Aug 24 | Sale | 61.25 | 17,986 | 1,101,642 | 27,868 | Aug 28 05:28 PM | Plenge Robert M | EVP, Chief Research Officer | Aug 03 | Sale | 61.14 | 732 | 44,754 | 6,584 | Aug 07 05:24 PM | Weese Michelle | EVP, Corporate Affairs | Jul 01 | Option Exercise | 0.00 | 1,885 | 0 | 4,135 | Jul 05 05:26 PM | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Jul 01 | Option Exercise | 0.00 | 9,357 | 0 | 52,032 | Jul 05 05:23 PM | Lenkowsky Adam | EVP, Chief Commercial Officer | Jun 03 | Option Exercise | 0.00 | 1,077 | 0 | 1,077 | Jun 06 07:39 PM | VESSEY RUPERT | EVP & President, Research | May 03 | Sale | 67.06 | 50,385 | 3,378,818 | 47,751 | May 04 05:51 PM | Greenlees Sharon | SVP & Controller | May 02 | Option Exercise | 0.00 | 1,017 | 0 | 728 | May 03 07:36 PM | Mily Elizabeth | EVP, Strategy & BD | Apr 01 | Option Exercise | 0.00 | 6,346 | 0 | 35,873 | Apr 04 08:40 PM | Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | Apr 01 | Option Exercise | 0.00 | 3,306 | 0 | 4,918 | Apr 04 08:40 PM | Mily Elizabeth | EVP, Strategy & BD | Mar 10 | Option Exercise | 0.00 | 29,636 | 0 | 38,173 | Mar 14 08:40 PM | VESSEY RUPERT | EVP & President, Research | Mar 10 | Option Exercise | 0.00 | 66,935 | 0 | 118,263 | Mar 14 08:34 PM | LEUNG SANDRA | EVP, General Counsel | Mar 10 | Option Exercise | 0.00 | 57,990 | 0 | 356,920 | Mar 14 08:28 PM | Powell Ann | EVP, Chief Human Resources | Mar 10 | Option Exercise | 0.00 | 34,447 | 0 | 53,100 | Mar 14 08:18 PM | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Mar 10 | Option Exercise | 0.00 | 38,978 | 0 | 54,035 | Mar 14 08:18 PM | Weese Michelle | EVP, Corporate Affairs | Mar 10 | Option Exercise | 0.00 | 1,590 | 0 | 2,793 | Mar 14 08:14 PM | Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | Mar 10 | Option Exercise | 0.00 | 2,447 | 0 | 2,447 | Mar 14 08:12 PM | Caforio Giovanni | Board Chair and CEO | Mar 10 | Option Exercise | 0.00 | 234,676 | 0 | 431,381 | Mar 14 08:13 PM | Elkins David V | EVP, Chief Financial Officer | Mar 10 | Option Exercise | 0.00 | 71,871 | 0 | 185,308 | Mar 14 08:13 PM | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | Mar 10 | Option Exercise | 0.00 | 59,111 | 0 | 91,880 | Mar 14 08:13 PM | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Mar 10 | Option Exercise | 0.00 | 2,836 | 0 | 4,648 | Mar 14 08:14 PM | Caforio Giovanni | Board Chair and CEO | Feb 06 | Sale | 74.65 | 240,000 | 17,916,000 | 236,104 | Feb 08 08:09 PM | Powell Ann | EVP, Chief Human Resources | Feb 06 | Sale | 74.69 | 11,183 | 835,258 | 23,043 | Feb 08 08:09 PM | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Feb 01 | Option Exercise | 0.00 | 2,543 | 0 | 2,543 | Feb 03 07:18 PM |
|